HCW Biologics Company

HCW Biologics is developing immunotherapies to lengthen healthspan by disrupting the link between cellular senescence and disease.

Total Funding: $18.1M
Headquarters: United States
Funding Status: Early Stage Venture
Employee Number: 1-10
Estimated Revenue: $1M to $10M
Last Funding Type: Series B
Number Of Exists: Series B
Technology: Geroscience
Investor Type: Company
Investors Number: 2
Founded Date: 2018-04-01
Industry: Others